BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38087730)

  • 41. Cervical cancer screening and prevention in low-resource settings.
    Bradford L; Goodman A
    Clin Obstet Gynecol; 2013 Mar; 56(1):76-87. PubMed ID: 23337844
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of metastatic cervical cancer: future directions involving targeted agents.
    Diaz-Padilla I; Monk BJ; Mackay HJ; Oaknin A
    Crit Rev Oncol Hematol; 2013 Mar; 85(3):303-14. PubMed ID: 22883215
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cervical cancer screening and prevention in Kazakhstan and Central Asia.
    Aimagambetova G; Chan CK; Ukybassova T; Imankulova B; Balykov A; Kongrtay K; Azizan A
    J Med Screen; 2021 Mar; 28(1):48-50. PubMed ID: 31980007
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cervical smears: towards an optimal screening for cervical cancer].
    Leroy JL; Boman F
    Presse Med; 2003 Feb; 32(4):174-80. PubMed ID: 12610474
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Screening for cervical cancer in French Guiana: screening rates from 2006 to 2011.
    Douine M; Roué T; Lelarge C; Adenis A; Thomas N; Nacher M
    Bull Soc Pathol Exot; 2015 Dec; 108(5):355-9. PubMed ID: 26608273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Screening for cervical cancer, a priority in Zimbabwe?
    Rutgers S; Verkuyl D
    Cent Afr J Med; 2000 Mar; 46(3):81-6. PubMed ID: 14674218
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Cervical cancer screening in rural Madagascar: Feasibility, coverage and incidence].
    Dumont A; Bessières N; Benbassa A; Razafindrafara G; Rabearison F; Philippe HJ
    J Gynecol Obstet Hum Reprod; 2017 Apr; 46(4):327-332. PubMed ID: 28643659
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cervical cancer screening in India: strategies revisited.
    Juneja A; Sehgal A; Sharma S; Pandey A
    Indian J Med Sci; 2007 Jan; 61(1):34-47. PubMed ID: 17197739
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improved control of invasive cervical cancer in Sweden over six decades by earlier clinical detection and better treatment.
    Sparén P; Gustafsson L; Friberg LG; Pontén J; Bergström R; Adami HO
    J Clin Oncol; 1995 Mar; 13(3):715-25. PubMed ID: 7884431
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Perspective on cervical cancer: why prevent?
    Morrow CP; Cozen W
    J Cell Biochem Suppl; 1995; 23():61-70. PubMed ID: 8747379
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors associated with Pap smear screening among French women visiting a general practitioner in the Rhône-Alpes region.
    Oussaid N; Lutringer-Magnin D; Barone G; Haesebaert J; Lasset C
    Rev Epidemiol Sante Publique; 2013 Oct; 61(5):437-45. PubMed ID: 24012357
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
    Canfell K; Kim JJ; Brisson M; Keane A; Simms KT; Caruana M; Burger EA; Martin D; Nguyen DTN; Bénard É; Sy S; Regan C; Drolet M; Gingras G; Laprise JF; Torode J; Smith MA; Fidarova E; Trapani D; Bray F; Ilbawi A; Broutet N; Hutubessy R
    Lancet; 2020 Feb; 395(10224):591-603. PubMed ID: 32007142
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Interval between two smear tests for cervical cancer screening and characteristics of women with a short interval: Study in the department of Isère].
    Caporossi A; Olicard C; Seigneurin A; Garnier A
    Rev Epidemiol Sante Publique; 2019 May; 67(3):143-147. PubMed ID: 30981595
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Organized cervical cancer screening at last in France!!].
    Baldauf JJ
    Gynecol Obstet Fertil Senol; 2019 Jan; 47(1):1-2. PubMed ID: 30555033
    [No Abstract]   [Full Text] [Related]  

  • 55. Human papillomavirus testing in the prevention of cervical cancer.
    Schiffman M; Wentzensen N; Wacholder S; Kinney W; Gage JC; Castle PE
    J Natl Cancer Inst; 2011 Mar; 103(5):368-83. PubMed ID: 21282563
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Unindicated cervical cancer screening in adolescent females within a large healthcare system in the United States.
    Hosier H; Sheth SS; Oliveira CR; Perley LE; Vash-Margita A
    Am J Obstet Gynecol; 2021 Dec; 225(6):649.e1-649.e9. PubMed ID: 34256029
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cervical cancer screening in Switzerland - current practice and future challenges].
    Untiet S; Schmidt N; Low N; Petignat P
    Ther Umsch; 2013 Apr; 70(4):223-30. PubMed ID: 23535549
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Practice Bulletin No. 168: Cervical Cancer Screening and Prevention.
    Obstet Gynecol; 2016 Oct; 128(4):e111-e130. PubMed ID: 27661651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [New drugs approval: Trastuzumab-deruxtecan - HER2-low metastatic breast cancer].
    Gorgeu V; Grellety T
    Bull Cancer; 2023 Jun; 110(6):597-598. PubMed ID: 37045733
    [No Abstract]   [Full Text] [Related]  

  • 60. [Prevention of cervical cancer. Screening and vaccination: methods of use].
    Boulanger JC
    Gynecol Obstet Fertil; 2011; 39(7-8):405-6. PubMed ID: 21757389
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.